Fisher & Paykel Healthcare Corporation Limited FSPKF
OTC PK
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.35B | 1.30B | 1.26B | 1.23B | 1.20B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.35B | 1.30B | 1.26B | 1.23B | 1.20B |
| Cost of Revenue | 492.02M | 473.76M | 463.30M | 454.75M | 444.94M |
| Gross Profit | 862.60M | 825.18M | 801.65M | 778.42M | 753.13M |
| SG&A Expenses | 351.08M | 336.71M | 327.91M | 322.93M | 317.06M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 981.33M | 946.09M | 926.50M | 912.83M | 896.61M |
| Operating Income | 373.29M | 352.85M | 338.45M | 320.34M | 301.46M |
| Income Before Tax | 370.42M | 352.27M | 340.22M | 319.21M | 297.47M |
| Income Tax Expenses | 95.58M | 89.12M | 84.20M | 79.48M | 74.57M |
| Earnings from Continuing Operations | 274.83 | 263.15 | 256.02 | 239.73 | 222.90 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 274.83M | 263.15M | 256.02M | 239.73M | 222.90M |
| EBIT | 373.29M | 352.85M | 338.45M | 320.34M | 301.46M |
| EBITDA | 445.54M | 423.35M | 408.31M | 388.90M | 368.52M |
| EPS Basic | 0.47 | 0.45 | 0.44 | 0.41 | 0.38 |
| Normalized Basic EPS | 0.39 | 0.38 | 0.36 | 0.34 | 0.32 |
| EPS Diluted | 0.47 | 0.45 | 0.43 | 0.41 | 0.38 |
| Normalized Diluted EPS | 0.39 | 0.37 | 0.36 | 0.34 | 0.31 |
| Average Basic Shares Outstanding | 2.35B | 2.35B | 2.35B | 2.34B | 2.34B |
| Average Diluted Shares Outstanding | 2.36B | 2.36B | 2.36B | 2.36B | 2.36B |
| Dividend Per Share | 0.30 | 0.28 | 0.25 | 0.25 | 0.25 |
| Payout Ratio | 47.85% | 48.25% | 48.58% | 46.75% | 44.64% |